This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Piramal Enterprises Limited. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Ramswaroop Mundada: Innovator in Pharmaceutical Chemistry
Introduction
Ramswaroop Mundada is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target critical pathways in cancer and inflammation treatment.
Latest Patents
Mundada holds a patent for "Imidazo [4,5-C]quinoline derivatives and their use in the treatment of tumors and/or inflammation." This invention provides compounds of formula (I) that are designed to address diseases mediated by phosphatidylinositol-3-kinase (PBK), mammalian target of rapamycin (mTOR), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6). His work is particularly focused on the treatment of cancer and inflammation, showcasing the potential of these derivatives in therapeutic applications.
Career Highlights
Mundada is associated with Piramal Enterprises Limited, a leading company in the pharmaceutical sector. His role at the company has allowed him to engage in innovative research and development, contributing to advancements in drug formulation and therapeutic strategies.
Collaborations
Mundada has worked alongside talented colleagues such as Sanjay Kumar and Ram Asrey Vishwakarma. Their collaborative efforts have fostered a productive environment for innovation and discovery in the pharmaceutical field.
Conclusion
Ramswaroop Mundada's contributions to pharmaceutical chemistry, particularly through his patented work on imidazo[4,5-C]quinoline derivatives, highlight his role as an innovator in the treatment of cancer and inflammation. His ongoing work at Piramal Enterprises Limited continues to impact the industry positively.